Innova Captab Limited (INNOVACAP.NS)
INR 875.7
(5.21%)
INR 875.7
(5.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.66 Billion INR | 35.9% |
| 2022 | 1.22 Billion INR | 24.52% |
| 2021 | 987.68 Million INR | 77.56% |
| 2020 | 558.57 Million INR | 9.76% |
| 2019 | 506.16 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 443 Million INR | 1.22% |
| 2023 Q2 | 438.17 Million INR | 32.81% |
| 2023 Q3 | 469.37 Million INR | 7.12% |
| 2023 Q1 | 329.93 Million INR | -68.23% |
| 2023 FY | - INR | 35.9% |
| 2023 Q4 | 437.64 Million INR | -6.76% |
| 2022 Q3 | 369.3 Million INR | 0.0% |
| 2022 FY | - INR | 24.52% |
| 2022 Q4 | 1.03 Billion INR | 181.21% |
| 2021 FY | - INR | 77.56% |
| 2020 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | 82.652% |
| Hester Biosciences Limited | 539.47 Million INR | -209.25% |
| Aarti Drugs Limited | 3.24 Billion INR | 48.646% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | 57.326% |
| Albert David Limited | 1.04 Billion INR | -59.582% |
| Alembic Limited | 1.11 Billion INR | -49.445% |
| Alkem Laboratories Limited | 24.19 Billion INR | 93.105% |
| Bafna Pharmaceuticals Limited | 114.58 Million INR | -1355.984% |
| Bajaj HealthCare Limited | 406.23 Million INR | -310.673% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.99 Million INR | -12737.104% |
| Brooks Laboratories Limited | 41.72 Million INR | -3898.059% |
| Eris Lifesciences Limited | 6.98 Billion INR | 76.121% |
| FDC Limited | 3.38 Billion INR | 50.72% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | 75.691% |
| Gufic Biosciences Limited | 1.48 Billion INR | -12.687% |
| Hikal Limited | 2.69 Billion INR | 38.032% |
| Ind-Swift Limited | 1.06 Billion INR | -56.639% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | 35.997% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -415.77% |
| Jubilant Pharmova Limited | 8 Billion INR | 79.162% |
| Lincoln Pharmaceuticals Limited | 1.34 Billion INR | -24.193% |
| Lupin Limited | 36.96 Billion INR | 95.487% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -853.614% |
| Medico Remedies Limited | 129.09 Million INR | -1192.322% |
| Morepen Laboratories Limited | 1.72 Billion INR | 3.34% |
| Nectar Lifesciences Limited | 1.53 Billion INR | -8.643% |
| Orchid Pharma Limited | 1.41 Billion INR | -17.555% |
| Procter & Gamble Health Limited | 3.07 Billion INR | 45.735% |
| RPG Life Sciences Limited | 1.28 Billion INR | -30.184% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -480.433% |
| Sigachi Industries Limited | 883.39 Million INR | -88.851% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 159.12% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | 64.331% |
| Themis Medicare Limited | 562.6 Million INR | -196.532% |
| Unichem Laboratories Limited | 742.35 Million INR | -124.732% |
| Vaishali Pharma Limited | 31.71 Million INR | -5160.982% |
| Wanbury Limited | 985.49 Million INR | -69.287% |
| Windlas Biotech Limited | 781.72 Million INR | -113.415% |
| ZIM Laboratories Limited | 462.09 Million INR | -261.03% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | 75.686% |
| Ipca Laboratories Limited | 13.29 Billion INR | 87.456% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 98.794% |
| Venus Remedies Limited | 711.8 Million INR | -134.379% |
| Sakar Healthcare Limited | 393.26 Million INR | -324.217% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 97.3% |
| Divi's Laboratories Limited | 25.43 Billion INR | 93.44% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | 29.213% |
| Mankind Pharma Limited | 28.09 Billion INR | 94.062% |
| Sequent Scientific Limited | 549.8 Million INR | -203.439% |
| Laurus Labs Limited | 8 Billion INR | 79.162% |
| Neuland Laboratories Limited | 4.74 Billion INR | 64.864% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 82.128% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 85.293% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 97.033% |
| Amrutanjan Health Care Limited | 681.59 Million INR | -144.765% |
| Wockhardt Limited | 1.08 Billion INR | -54.473% |
| Bal Pharma Limited | 345.59 Million INR | -382.74% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 98.11% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -12.798% |
| Par Drugs and Chemicals Limited | 228.17 Million INR | -631.157% |
| Caplin Point Laboratories Limited | 6.18 Billion INR | 73.021% |
| Shilpa Medicare Limited | 2.58 Billion INR | 35.536% |
| Valiant Laboratories Limited | 12.73 Million INR | -12996.083% |
| Ajanta Pharma Limited | 12.56 Billion INR | 86.723% |
| Aarey Drugs & Pharmaceuticals Limited | 45.16 Million INR | -3593.812% |
| Granules India Limited | 8.6 Billion INR | 80.61% |
| Medicamen Biotech Limited | 245.66 Million INR | -579.113% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -287.73% |
| Piramal Enterprises Limited | -3.86 Billion INR | 143.208% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 95.235% |
| NATCO Pharma Limited | 18.79 Billion INR | 91.124% |
| Suven Life Sciences Limited | -992.78 Million INR | 268.044% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 2116.645% |
| Strides Pharma Science Limited | 3.76 Billion INR | 55.685% |
| Indoco Remedies Limited | 2.64 Billion INR | 36.975% |
| Alpa Laboratories Limited | 229.96 Million INR | -625.475% |
| Lasa Supergenerics Limited | -65.08 Million INR | 2663.476% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 144.709% |